UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 3, 2022

Accession Number:	0001193125-22-050259
Submission Type:	POS AM
CIK: 0001560241 Company Name: G1 Therapeutics, Inc. File Number: 333-257640